• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨大垂体腺瘤 - 特殊考虑。

Giant Pituitary Adenoma - Special Considerations.

机构信息

Department of Neurosurgery, Warren Alpert Medical School of Brown University, 222 Richmond Street, Providence, RI 02903, USA. Electronic address: https://twitter.com/@oliverytang.

Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, 90 Bergen Street Room, Suite 8100, Newark, NJ 07101, USA; Department of Neurological Surgery, Rutgers New Jersey Medical School, 90 Bergen Street Room, Suite 8100, Newark, NJ 07101, USA.

出版信息

Otolaryngol Clin North Am. 2022 Apr;55(2):351-379. doi: 10.1016/j.otc.2021.12.008.

DOI:10.1016/j.otc.2021.12.008
PMID:35365313
Abstract

Giant pituitary adenomas (GPAs) comprise 5% to 15% of pituitary adenomas, but have higher rates of extrasellar invasion, subtotal resection, surgical morbidity, and recurrence. With the possible exception of giant prolactinomas, GPAs require surgical decompression. On review of 3 decades of case series encompassing 699 microsurgical transsphenoidal (MT), 1060 endoscopic endonasal trans-sphenoidal (EET), and 513 transcranial (TC) patients, gross total resection and recurrence rates were comparable across modalities, but the EET approach had lower perioperative mortality and superior restoration of visual function. Each approach has unique indications. Combined EET-TC approaches for minimizing residual tumor represent another area of study.

摘要

巨大垂体腺瘤(GPAs)占垂体腺瘤的 5%至 15%,但具有更高的鞍外侵犯、次全切除、手术发病率和复发率。除了巨大泌乳素瘤之外,GPAs 需要手术减压。对涵盖 699 例显微镜下经蝶窦(MT)、1060 例内镜经鼻蝶窦(EET)和 513 例经颅(TC)患者的 30 年病例系列回顾显示,各种方法的大体全切除率和复发率相当,但 EET 方法的围手术期死亡率较低,视觉功能恢复更好。每种方法都有其独特的适应证。联合 EET-TC 方法以最大限度地减少残留肿瘤是另一个研究领域。

相似文献

1
Giant Pituitary Adenoma - Special Considerations.巨大垂体腺瘤 - 特殊考虑。
Otolaryngol Clin North Am. 2022 Apr;55(2):351-379. doi: 10.1016/j.otc.2021.12.008.
2
Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection.经鼻内镜蝶窦入路切除大型和巨大型垂体腺瘤:机构经验和影响切除程度的预测因素。
J Neurosurg. 2014 Jul;121(1):75-83. doi: 10.3171/2014.3.JNS131679. Epub 2014 May 2.
3
Endoscopic endonasal transsphenoidal removal of recurrent and regrowing pituitary adenomas: experience on a 59-patient series.内镜经鼻蝶窦切除复发性和再生长垂体腺瘤:59 例患者系列经验。
World Neurosurg. 2013 Sep-Oct;80(3-4):342-50. doi: 10.1016/j.wneu.2012.10.008. Epub 2012 Oct 6.
4
Giant pituitary adenomas: surgical outcomes of 50 cases operated on by the endonasal endoscopic approach.巨大垂体腺瘤经鼻内镜手术 50 例的治疗效果分析。
World Neurosurg. 2014 Jul-Aug;82(1-2):e281-90. doi: 10.1016/j.wneu.2013.08.028. Epub 2013 Aug 29.
5
Reoperative endoscopic endonasal surgery for residual or recurrent pituitary adenomas.经鼻内镜垂体腺瘤术后残留或复发的再次手术治疗。
J Neurosurg. 2017 Aug;127(2):397-408. doi: 10.3171/2016.8.JNS152709. Epub 2016 Oct 28.
6
Comparison of Surgical Modalities for Giant Pituitary Adenoma: A Systematic Review and Meta-Analysis of 1413 Patients.巨大垂体腺瘤手术方式的比较:对1413例患者的系统评价和荟萃分析
Oper Neurosurg (Hagerstown). 2025 Jan 1;28(1):1-18. doi: 10.1227/ons.0000000000001238. Epub 2024 Jul 5.
7
Surgical Outcome of Endoscopic Endonasal Surgery of Large and Giant Pituitary Adenomas: An Institutional Experience from the Middle East.内镜经鼻蝶窦手术治疗大型和巨大型垂体腺瘤的手术结果:来自中东的机构经验。
World Neurosurg. 2019 Dec;132:e802-e811. doi: 10.1016/j.wneu.2019.08.004. Epub 2019 Aug 9.
8
Treatment strategies for giant pituitary adenomas in the era of endoscopic transsphenoidal surgery: a multicenter series.内镜经鼻蝶窦手术时代巨大垂体腺瘤的治疗策略:多中心系列研究。
J Neurosurg. 2021 Aug 13;136(3):776-785. doi: 10.3171/2021.1.JNS203982. Print 2022 Mar 1.
9
Endoscopic Endonasal Approach to Giant Pituitary Adenomas: Surgical Outcomes and Review of the Literature.内镜经鼻入路切除巨大垂体腺瘤:手术结果及文献复习。
World Neurosurg. 2021 May;149:e1043-e1055. doi: 10.1016/j.wneu.2021.01.019. Epub 2021 Jan 29.
10
Comparison of outcomes between a less experienced surgeon using a fully endoscopic technique and a very experienced surgeon using a microscopic transsphenoidal technique for pituitary adenoma.经验较少的外科医生采用完全内镜技术与经验非常丰富的外科医生采用显微镜下经蝶窦技术治疗垂体腺瘤的疗效比较。
J Neurosurg. 2016 Mar;124(3):596-604. doi: 10.3171/2015.4.JNS15102. Epub 2015 Oct 16.

引用本文的文献

1
Advancements in Molecular Diagnosis and Pharmacotherapeutic Strategies for Invasive Pituitary Adenomas.侵袭性垂体腺瘤的分子诊断与药物治疗策略进展
Immun Inflamm Dis. 2024 Dec;12(12):e70098. doi: 10.1002/iid3.70098.
2
A case of acute hydrocephalus due to a giant prolactinoma rescued by transventricular neuroendoscopic tumorectomy.1例巨大催乳素瘤所致急性脑积水经脑室神经内镜肿瘤切除术救治成功
Surg Neurol Int. 2023 Jan 27;14:30. doi: 10.25259/SNI_1060_2022. eCollection 2023.
3
Staged surgery for irregular giant pituitary adenomas: A report of two cases.
不规则巨大垂体腺瘤的分期手术:两例报告
Oncol Lett. 2023 Feb 7;25(3):118. doi: 10.3892/ol.2023.13704. eCollection 2023 Mar.
4
The effect of endoscopic transsphenoidal somatotroph tumors resection on pituitary hormones: systematic review and meta-analysis.内镜经蝶窦切除生长激素腺瘤对垂体激素的影响:系统评价和荟萃分析。
World J Surg Oncol. 2023 Mar 1;21(1):71. doi: 10.1186/s12957-023-02958-2.
5
Moving toward a standardized diagnostic statement of pituitary adenoma using an information extraction model: a real-world study based on electronic medical records.采用信息提取模型为垂体腺瘤制定标准化诊断陈述:基于电子病历的真实世界研究。
BMC Med Inform Decis Mak. 2022 Dec 7;22(1):319. doi: 10.1186/s12911-022-02031-0.
6
Analysis of neuroendoscopy for the treatment of macroadenomas and giant pituitary adenomas.神经内镜治疗大腺瘤和巨大垂体腺瘤的分析
Front Surg. 2022 Aug 11;9:956345. doi: 10.3389/fsurg.2022.956345. eCollection 2022.